|
US6214801B1
(en)
|
1996-01-23 |
2001-04-10 |
The Regents Of The University Of Michigan |
Imidazo[1,2-a]pyridine C-nucleosides as antiviral agents
|
|
NZ502882A
(en)
|
1997-07-30 |
2002-02-01 |
Glaxo Group Ltd |
Lyxofuranosyl benzimidazoles as antiviral agents
|
|
DE19741715A1
(de)
*
|
1997-09-22 |
1999-03-25 |
Hoechst Ag |
Pentopyranosyl-Nucleosid, seine Herstellung und Verwendung
|
|
GB0008939D0
(en)
|
2000-04-11 |
2000-05-31 |
Glaxo Group Ltd |
Process for preparing substituted benzimidazole compounds
|
|
CA2441177A1
(en)
|
2001-03-12 |
2002-09-19 |
Avanir Pharmaceuticals |
Benzimidazole compounds for modulating ige and inhibiting cellular proliferation
|
|
TWI276631B
(en)
|
2002-09-12 |
2007-03-21 |
Avanir Pharmaceuticals |
Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
|
|
WO2004024655A2
(en)
|
2002-09-12 |
2004-03-25 |
Avanir Pharmaceuticals |
Phenyl-indole compounds for modulating ige and inhibiting cellular proliferation
|
|
WO2005012242A2
(en)
*
|
2003-08-01 |
2005-02-10 |
Janssen Pharmaceutica Nv |
Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides
|
|
WO2005049582A1
(en)
*
|
2003-11-14 |
2005-06-02 |
Auspex Pharmaceuticals, Inc. |
Method of preparation of novel nucleoside analogs and uses
|
|
KR100944301B1
(ko)
*
|
2005-02-22 |
2010-02-24 |
더 리젠츠 오브 더 유니버시티 오브 미시간 |
Ｍｄｍ２의 소분자 억제제 및 이의 용도
|
|
DE102005019549A1
(de)
*
|
2005-04-25 |
2006-12-14 |
Beiersdorf Ag |
Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Diaminobenzimidazol
|
|
WO2007070947A1
(en)
*
|
2005-12-22 |
2007-06-28 |
Alchemia Ltd |
Antibacterial agents
|
|
US10238599B2
(en)
|
2006-01-19 |
2019-03-26 |
The Regents Of The University Of Michigan |
Composition and method for treating congenital cytomegalovirus induced hearing loss
|
|
US9889156B2
(en)
|
2006-01-19 |
2018-02-13 |
The Regents Of The University Of Michigan |
Method for treating noise-induced hearing loss (NIHL)
|
|
US8927528B2
(en)
|
2006-01-19 |
2015-01-06 |
The Regents Of The University Of Michigan |
Composition for treating hearing loss
|
|
USRE46372E1
(en)
|
2006-01-19 |
2017-04-25 |
The Regents Of The Univerity Of Michigan |
Method for treating hearing loss
|
|
US7951845B2
(en)
|
2006-01-19 |
2011-05-31 |
The Regents Of The University Of Michigan |
Composition and method of treating hearing loss
|
|
US9919008B2
(en)
|
2006-01-19 |
2018-03-20 |
The Regents Of The University Of Michigan |
Method for treating age-related hearing loss (ARHL)
|
|
US9770433B2
(en)
|
2006-01-19 |
2017-09-26 |
The Regents Of The University Of Michigan |
Composition and method for treating tinnitus
|
|
US8338397B2
(en)
|
2006-01-19 |
2012-12-25 |
The Regents Of The University Of Michigan |
Composition and method of treating side effects from antibiotic treatment
|
|
KR101654007B1
(ko)
|
2007-08-15 |
2016-09-05 |
아이오니스 파마수티컬즈, 인코포레이티드 |
테트라하이드로피란 핵산 유사체
|
|
WO2009100045A1
(en)
*
|
2008-02-04 |
2009-08-13 |
Translational Genomics Research Institute |
Compounds, pharmaceutical compositions and methods of use of hydroxamic acid derivatives
|
|
US8530640B2
(en)
|
2008-02-07 |
2013-09-10 |
Isis Pharmaceuticals, Inc. |
Bicyclic cyclohexitol nucleic acid analogs
|
|
JP5764064B2
(ja)
|
2008-09-26 |
2015-08-12 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
抗糖尿病薬として有用な新規な環状ベンゾイミダゾール誘導体
|
|
MX2011004258A
(es)
|
2008-10-22 |
2011-06-01 |
Merck Sharp & Dohme |
Derivados de bencimidazol ciclicos novedosos utiles como agentes anti-diabeticos.
|
|
MX2011004505A
(es)
|
2008-10-29 |
2011-05-31 |
Merck Sharp & Dohme |
Derivados novedosos de bencimidazol ciclico, utiles como agentes antidiabeticos.
|
|
CA2741672A1
(en)
|
2008-10-31 |
2010-05-06 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
WO2010090969A1
(en)
|
2009-02-06 |
2010-08-12 |
Isis Pharmaceuticals, Inc. |
Tetrahydropyran nucleic acid analogs
|
|
WO2010091308A2
(en)
|
2009-02-06 |
2010-08-12 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds and methods
|
|
CA2786314A1
(en)
|
2010-02-25 |
2011-09-01 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
JP6005628B2
(ja)
|
2010-04-28 |
2016-10-12 |
アイオーニス ファーマシューティカルズ， インコーポレーテッドＩｏｎｉｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． |
修飾ヌクレオシド、その類似体、およびこれらから調製されるオリゴマー化合物
|
|
US8546344B2
(en)
|
2010-10-28 |
2013-10-01 |
Viropharma Incorporated |
Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl)-1H-benzimidazole
|
|
US9382294B2
(en)
|
2013-03-01 |
2016-07-05 |
Los Alamos National Security, Llc |
Broad spectrum antibiotic compounds and use thereof
|
|
DK3137476T3
(da)
|
2014-04-28 |
2019-11-18 |
Ionis Pharmaceuticals Inc |
Linker-modificerede oligomerforbindelser
|
|
WO2016089845A1
(en)
*
|
2014-12-01 |
2016-06-09 |
Virginia Commonwealth University |
A convergent approach to the total synthesis of telmisartan via a suzuki cross-coupling reaction
|
|
RU2629670C2
(ru)
*
|
2016-08-04 |
2017-08-31 |
Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) |
2-Амино-5,6-дифтор-1-(бета-D-рибофуранозил)-бензимидазол, способ получения и противовирусная активность его в отношении вируса герпеса простого 1-го типа
|
|
EP3907230B1
(en)
|
2020-03-30 |
2024-08-28 |
Biometrix Technology Inc. |
Novel benzimidazole derivatives, preparation method thereof and use thereof as anti-cancer agent comprising the same
|
|
KR102583547B1
(ko)
|
2020-03-30 |
2023-10-06 |
(주)바이오메트릭스 테크놀로지 |
신규한 벤지미다졸 유도체, 이의 제조방법 및 이의 항암제 용도
|
|
JP7376108B2
(ja)
*
|
2020-06-23 |
2023-11-08 |
バイオメトリックス テクノロジーズ インコーポレイテッド |
新規なベンズイミダゾール誘導体、その製造方法及びその抗癌剤または抗ウイルス剤としての用途
|
|
KR102449266B1
(ko)
|
2020-06-23 |
2022-09-30 |
(주)바이오메트릭스 테크놀로지 |
항암 활성 그리고 항바이러스 활성을 갖는 신규한 벤지미다졸-탄수화물 결합체 화합물(Benzimidazole carbohydrate conjugate compound) 및 이의 제조 방법
|
|
KR102342313B1
(ko)
|
2021-08-27 |
2021-12-24 |
(주)바이오메트릭스 테크놀로지 |
벤지미다졸-탄수화물 결합체 화합물을 포함하는 미셀, 이의 제조방법, 이의 항암제 또는 항바이러스제로서의 용도
|
|
CN119119151A
(zh)
*
|
2024-09-04 |
2024-12-13 |
斯坦德药典标准物质研发(湖北)有限公司 |
一种马立巴韦的制备方法
|